Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants

Detalles Bibliográficos
Autores principales: Hentzien, Maxime, Owen, Andrew, Strub-Wourgaft, Nathalie, Pérez-Casas, Carmen, Trøseid, Marius, Calmy, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597299/
https://www.ncbi.nlm.nih.gov/pubmed/36312942
http://dx.doi.org/10.3389/fmicb.2022.998287
_version_ 1784816063477710848
author Hentzien, Maxime
Owen, Andrew
Strub-Wourgaft, Nathalie
Pérez-Casas, Carmen
Trøseid, Marius
Calmy, Alexandra
author_facet Hentzien, Maxime
Owen, Andrew
Strub-Wourgaft, Nathalie
Pérez-Casas, Carmen
Trøseid, Marius
Calmy, Alexandra
author_sort Hentzien, Maxime
collection PubMed
description
format Online
Article
Text
id pubmed-9597299
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95972992022-10-27 Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants Hentzien, Maxime Owen, Andrew Strub-Wourgaft, Nathalie Pérez-Casas, Carmen Trøseid, Marius Calmy, Alexandra Front Microbiol Microbiology Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9597299/ /pubmed/36312942 http://dx.doi.org/10.3389/fmicb.2022.998287 Text en Copyright © 2022 Hentzien, Owen, Strub-Wourgaft, Pérez-Casas, Trøseid and Calmy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Hentzien, Maxime
Owen, Andrew
Strub-Wourgaft, Nathalie
Pérez-Casas, Carmen
Trøseid, Marius
Calmy, Alexandra
Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
title Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
title_full Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
title_fullStr Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
title_full_unstemmed Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
title_short Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
title_sort rethinking treatment paradigms for the deployment of sars-cov-2 antiviral drugs on the shifting landscape of new variants
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597299/
https://www.ncbi.nlm.nih.gov/pubmed/36312942
http://dx.doi.org/10.3389/fmicb.2022.998287
work_keys_str_mv AT hentzienmaxime rethinkingtreatmentparadigmsforthedeploymentofsarscov2antiviraldrugsontheshiftinglandscapeofnewvariants
AT owenandrew rethinkingtreatmentparadigmsforthedeploymentofsarscov2antiviraldrugsontheshiftinglandscapeofnewvariants
AT strubwourgaftnathalie rethinkingtreatmentparadigmsforthedeploymentofsarscov2antiviraldrugsontheshiftinglandscapeofnewvariants
AT perezcasascarmen rethinkingtreatmentparadigmsforthedeploymentofsarscov2antiviraldrugsontheshiftinglandscapeofnewvariants
AT trøseidmarius rethinkingtreatmentparadigmsforthedeploymentofsarscov2antiviraldrugsontheshiftinglandscapeofnewvariants
AT calmyalexandra rethinkingtreatmentparadigmsforthedeploymentofsarscov2antiviraldrugsontheshiftinglandscapeofnewvariants

Ejemplares similares